Evidence map›Paper›PMID 27795262›Full record

ArticleGenome announcements2016

Complete Genome Sequence of a Recombinant GII.P16-GII.4 Norovirus Detected in Kawasaki City, Japan, in 2016.

Yuki Matsushima, Tomomi Shimizu, Mariko Ishikawa, Ayako Komane, Nobuhiko Okabe, Akihide Ryo, Hirokazu Kimura, Kazuhiko Katayama, Hideaki Shimizu

Abstract read
In one paragraph

Article in Genome announcements, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Prospective, Real-time Metagenomic Sequencing During Norovirus Outbreak Reveals Discrete Transmission Clusters.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuki MatsushimaDivision of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan.
Tomomi ShimizuDivision of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan.
Mariko IshikawaDivision of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan.
Ayako KomaneDivision of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan.
Nobuhiko OkabeDivision of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan.
Akihide RyoDepartment of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.
Hirokazu KimuraInfectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kazuhiko KatayamaDepartment of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Hideaki ShimizuDivision of Virology, Kawasaki City Institute for Public Health, Kanagawa, Japan shimizu-h@city.kawasaki.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recombinant norovirus, GII.P16-GII.4_Sydney2012, was first detected from nine patients with gastroenteritis in Kawasaki City, Japan, in 2016. The viral genome showed nucleotide sequence identities of 95.1% and 97.2% to the closest strains in the regions of 5' terminus to ORF1 and ORF2 to 3' terminus, respectively.

Identifiers

PMID27795262
PMCPMC5054331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.